Cargando…
Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis
Acute myeloid leukemia (AML) is characterized by relapse and treatment resistance in a major fraction of patients, underlining the need of innovative AML targeting therapies. Here we analysed the therapeutic potential of an innovative biohybrid consisting of the tumor-associated peptide somatostatin...
Autores principales: | Vegi, Naidu M., Chakrabortty, Sabyasachi, Zegota, Maksymilian M., Kuan, Seah Ling, Stumper, Anne, Rawat, Vijay P. S., Sieste, Stefanie, Buske, Christian, Rau, Sven, Weil, Tanja, Feuring-Buske, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962389/ https://www.ncbi.nlm.nih.gov/pubmed/31941913 http://dx.doi.org/10.1038/s41598-019-57172-6 |
Ejemplares similares
-
Mitochondria
Targeted Protein-Ruthenium Photosensitizer
for Efficient Photodynamic Applications
por: Chakrabortty, Sabyasachi, et al.
Publicado: (2017) -
VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in mice
por: Gentner, Eva, et al.
Publicado: (2016) -
Dynamic Core–Shell Bioconjugates for Targeted Protein Delivery and Release
por: Seidler, Christiane, et al.
Publicado: (2018) -
A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis
por: Petropoulos, Konstantin, et al.
Publicado: (2008) -
Somatostatin Analogues for Receptor Targeted Photodynamic Therapy
por: Kaščáková, Slávka, et al.
Publicado: (2014)